1 |
Ajizian SJ, English BK, Meals EA. Specific inhibitors of p38 and extracellular signal regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma. J Infect Dis. 1999 ; 179 : 939-44.
DOI
|
2 |
Rashed AN, Afifi FU, Disi AM. Simple evaluation of the wound healing activity of a crude extract of Portulaca oleracea L. (growing in Jordan) in Mus musculus JVI-1. J Ethnopharmacol. 2003 ; 88 : 131-6.
DOI
|
3 |
Kim CH. The inhibitory effects of Portulaca oleracea L. on HCl-ethanol induced gastritis in rats. Kor J Herbol. 2009 ; 24 : 41-7.
|
4 |
Lim YY, Quaha EPL. Antioxidant properties of different cultivars of Portulaca oleracea. Food Chem. 2007 ; 103 : 734-40.
DOI
|
5 |
Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 ; 43 : 109-42.
|
6 |
MaCartney-Francis N, Allen JB, Mizel DE, Albina JI, Xie QW, Nathan CF, Wahl SM. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med. 1993 ; 178 : 749-54.
DOI
|
7 |
Bishop-Bailey D, Calatayud S, Warner TD, Hla T, Michell A. Prostaglandins and the regulation of tumor growth. J Environ Pathol Tox Oncol. 2002 ; 21 : 93-101.
|
8 |
Oh CH translation. simple immunology. Seoul : Seoul medical korea. 2006 : 161-200.
|
9 |
Cobb MH, Goldsmith EJ. Dimerization in MAPkinase signaling. Trends Biochem Sci. 2000 ; 25 : 7–9.
DOI
|
10 |
Celec P. Nuclear factor kappa B-molecular biomedicine the nest generation. Biomed Pharmacother. 2004 ; 58 : 365-71.
DOI
|
11 |
Gang A, Aggarwal BB. Nuclear transcription factorkappaB as a target for cancer drug development. Leukemia. 2002 ; 16 : 1053-68.
DOI
|
12 |
Frenkel K, Wei H, Bhimani R et al. Inhibition of tumor promoter-mediated processes in mouse skin and bovine lens by caffeic acid phenethyl ester. Cancer Res. 1993 ; 53 : 1255-61.
|
13 |
Ferguson LR, Zhu ST, Harris PJ. Antioxidant and antigenotoxic effects of plant cell wall hydroxycinnamic acids in cultured HT-29 cells. Mol Nutr Food Res. 2005 ; 49 : 585-93.
DOI
|
14 |
Kang JR, Lee JY, Whang WK. Antioxidant and tyrosinase inhibitory activity of elscholtziae splendense. J Kor Soc Cosm. 2007 ; 13 : 163-70.
|
15 |
Kim DH, Park SJ, Jung JY, Kim SC, Byun SH. Antiinflammatory effects of the aqueous extract of Hwangnyenhaedok-tang in LPS-activated macrophage cells. Kor J Herbol. 2009 ; 24 : 39-47.
|
16 |
Behrens EM. Macrophage activation syndrome in rheumatic disease: What is the role of the antigen presenting cell? Autoimmun Rev. 2008 ; 7 : 305-8.
DOI
|
17 |
Lopez-Bojorquez LN, Dehesa AZ, Reyes-Teran G. Molecular mechanisms involved in the pathogenesis of septic shock. Arch Med Res. 2004 ; 35 : 465–79.
DOI
|
18 |
McDaniel ML, Kwon G, Hill JR, Marshall CA, Corbett JA. Cytokines and nitric oxide in islet inflammation and diabetes. Proc Soc Exp Biol Med. 1996 ; 211 : 24-32.
DOI
|
19 |
Beinke S, Ley SC. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem J. 2004 ; 382 : 393-409.
DOI
|
20 |
Moncada S, Higgs EA. Endogenous nitric oxide : physiology pathology and clinical relevance. Eur J Clin Ivest. 1991 ; 21 : 361-74.
DOI
|
21 |
Sakai N, Inada K, Okamoto M, Shizuri Y, Fukuyama Y. Portuloside A, a monoterpene glucoside from Portulaca oleracea. Phytochemistry. 1996 ; 42 : 1625-8.
DOI
|
22 |
Rocca B, FitzGerald GA. Cyclooxygenases and prostaglandins: shaping up the immune response. Int Immunopharmacol. 2002 ; 2 : 603-30.
DOI
|
23 |
Athman R, Philpott D. Innate immunity via Toll-like receptors and Nod proteins. Curr Opin Microbiol. 2004 ; 7 : 25-32.
DOI
|
24 |
Zhang XJ, Ji YB, Qu Z, Xia J, Wang L. Experimental studies on antibiotic functions of Portulaca oleracea L. in vitro. Chin J Microecol. 2002 ; 14 : 277-80.
|
25 |
Changquan L, Liwei D, Hailiang X, Min L, Wanyin W, Lin J. Ethanol extract of Portulaca oleracea L. protects against hypoxia-induced neuro damage through modulating endogenous erythropoietin expression. J Nutr Biochem. 2014 ; 23 : 385-91.
|
26 |
Hu LF, Xu XY, Wang BQ. Research and utilization situation of Portulaca Oleracea L in China. Pract J Med Pharm. 2003 ; 20 : 315-6.
|
27 |
Xiang L, Xing D, Wang W, Wang R, Ding Y, Du L. Alkaloids from Portulaca oleracea L. Phytochemistry. 2005 ; 66 : 2595-601.
DOI
|
28 |
Liu LX, Howe P, Zhou YF, Xu ZQ, Hocart C, Zhang R. Fatty acids and b-carotene in Australian purslane (Portulaca oleracea) varieties. J Chromatogr A. 2000 ; 893 : 207-13.
DOI
|
29 |
Karimi G, Hosseinzadeh H, Ettehad N. Evaluation of the gastric antiulcerogenic effects of Portulaca olerracea L. extracts in mice. Phytother Res. 2004 ; 18 : 484-7.
DOI
|